• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Novavax, Inc.

NASDAQ:NVAX

$1.27 $0.02 (1.60%)

REAL-TIME: Last trade at

Jump to this page for:

Related Resources

Greek Debt Swap, Payrolls Have the Street Divided

3/9/2012 by Nasdaq

The Fool Looks Ahead

3/3/2012 by DailyFinance

This Government Agency Can Make Drugmakers Billions

2/29/2012 by DailyFinance

5 Reasons Not to Worry About 2012

1/5/2012 by DailyFinance

Do the Shorts Know Something You Don't?

11/29/2011 by DailyFinance

Avoid This Biotech Stock

11/22/2011 by DailyFinance

This Just In: Upgrades and Downgrades

10/14/2011 by DailyFinance

Wall Street's Wrong About These Stocks

8/27/2011 by DailyFinance

Mid-Day Update: Stock Slide Continues Amid Concern Over Economy, Employment

8/4/2011 by Nasdaq

Three Major Indexes All Down Near 3%; Investor Concern Over Economy Grows

8/4/2011 by Nasdaq

Alternative Vaccine Manufacturers: Novavax and Ibio

4/28/2011 by Seeking Alpha

Novavax Has Over 400% Upside Potential

4/19/2011 by Seeking Alpha

Novavax Lands BARDA Contract and Licensing Deal

3/1/2011 by Seeking Alpha

Fortress Stands Tall on Earnings

3/1/2011 by Seeking Alpha

Stocks Shed Early Upside at Mid-Day; Investors Eye Bernanke Testimony, Oil Price Spike

3/1/2011 by Nasdaq

Mid-Day Update: Stocks Sinking Despite Positive Supply Data; Bernanke Talks Inflation

3/1/2011 by Nasdaq

Equities Update: Stocks Drop for Third Straight Session

8/12/2010 by Seeking Alpha

Novavax 2Q Earnings Down on High R&D Costs

8/6/2010 by Fox Business

UPDATE 1-Novavax flu vaccine trial shows mildly positive results

4/29/2010 by Reuters

UPDATE 1-Novavax reports positive data from flu vaccine study

3/24/2010 by Reuters

UPDATE 1-Novavax says H1N1 flu vaccine shows positive results

12/2/2009 by Reuters

Novavax begins H1N1 flu vaccine study in Mexico, shares rise

10/20/2009 by Reuters

Novavax shares fall on plans to sell stock

9/16/2009 by Reuters